The high level of controversy and media furore over diabetic drug Avandia has led many physicians and healthcare professionals to question the way in which drugs are approved in the America .
Avandia, the drug for diabetics at the heart of concerns, was approved by the Food and Drug Administration in 1999. It has generated about $3 billion in revenue per annum for the company that manufactures it, GlaxoSmithKline. Physicians are now questioning whether Avandia should ever have been approved.
Clifford J. Rosen, a leading endocrinologist in America, reportedly commented: "[Avandia] got on the market quickly, It sold a billion a year or more. It was really expensive drug, and I think the expectations were huge. The concern is if we're going to put somebody on a drug for a long period of time, we'd better make sure it's safe."
Healthcare professionals question diabetes approval
Thu, 09 Aug 2007
Join us